Last reviewed · How we verify

NCT03674515: BOUGE CANCER

Study of Program Interest "Bouge" to Improve the Daily Physical Activity in Processings Treatment of Non-metastatic Breast Cancer

Status unknown NA Last updated 17 September 2018
What this trial tests

NA trial testing Smartphone application "placebo" in Physical Activity in 214 participants. Status unknown.

Timeline
15 December 2017
Primary endpoint
12 December 2018
15 March 2019

Quick facts

Lead sponsorUniversity Hospital, Brest
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment214
Start date15 December 2017
Primary completion12 December 2018
Estimated completion15 March 2019
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Brest

Who can join

Adults 18 to 70, female only, with Physical Activity or Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate the "Bouge" digital program (smartphone application) to increase the daily physical activity of breast cancer patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Smartphone equipped with application "bouge" = Coach group

Trials testing the same drug.

Other recruiting trials for Physical Activity

Currently open trials in the same condition.

Other University Hospital, Brest trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03674515.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing